A Leading Global Biotech Selects Kneat
Kneat.com (TSXV:KSI) announced a new customer who according to the company is a global leader in biotechnology. Kneat developes and markets the next generation kneat Gx software platform where multiple business processes can be configured on the platform from equipment to computer system validation. This new customer of Kneat will deploy kneat’s software to a … Continued
Kneat.com (TSXV:KSI) announced a new customer who according to the company is a global leader in biotechnology.
Kneat developes and markets the next generation kneat Gx software platform where multiple business processes can be configured on the platform from equipment to computer system validation.
This new customer of Kneat will deploy kneat’s software to a number of their sites after the completion of product trails at an initial text site.
As quoted in the press release:
The customer will utilize our software for both capital and operational validation projects during the next phase of their rollout. This customer, with an estimated 20,000 employees working across multiple sites, will transition their existing paper based validation process to one that is completely digital.
“Throughout the pilot phase our new customer recognized the key business benefits of an end-to-end paperless process enabled by our innovative software. The functionality of our platform and our focus on customer service resulted in the win of another top tier customer.” said Eddie Ryan, Chief Executive Officer of Kneat.
By leveraging our enterprise e-validation software Kneat’s customers are increasing productivity and making the compliance effort easier for all their validation processes. Kneat continues to expand its customer pipeline and will report on further developments as they occur.
